Literature DB >> 22782563

Dissecting a role of evolutionary-conserved but noncritical disulfide bridges in cysteine-rich peptides using ω-conotoxin GVIA and its selenocysteine analogs.

Konkallu Hanumae Gowd1, Kirk D Blais, Keith S Elmslie, Andrew M Steiner, Baldomero M Olivera, Grzegorz Bulaj.   

Abstract

Conotoxins comprise a large group of peptidic neurotoxins that use diverse disulfide-rich scaffolds. Each scaffold is determined by an evolutionarily conserved pattern of cysteine residues. Although many structure-activity relationship studies confirm the functional and structural importance of disulfide crosslinks, there is growing evidence that not all disulfide bridges are critical in maintaining activities of conotoxins. To answer the fundamental biological question of what the role of noncritical disulfide bridges is, we investigated function and folding of disulfide-depleted analogs of ω-conotoxin GVIA (GVIA) that belongs to an inhibitory cystine knot motif family and blocks N-type calcium channels. Removal of a noncritical Cys1-Cys16 disulfide bridge in GVIA or its selenopeptide analog had, as predicted, rather minimal effects on the inhibitory activity on calcium channels, as well as on in vivo activity following intracranial administration. However, the disulfide-depleted GVIA exhibited significantly lower folding yields for forming the remaining two native disulfide bridges. The disulfide-depleted selenoconotoxin GVIA analog also folded with significantly lower yields, suggesting that the functionally noncritical disulfide pair plays an important cooperative role in forming the native disulfide scaffold. Taken together, our results suggest that distinct disulfide bridges may be evolutionarily preserved by the oxidative folding or/and stabilization of the bioactive conformation of a disulfide-rich scaffold.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22782563      PMCID: PMC3395435          DOI: 10.1002/bip.22047

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  57 in total

1.  Mechanisms for evolving hypervariability: the case of conopeptides.

Authors:  S G Conticello; Y Gilad; N Avidan; E Ben-Asher; Z Levy; M Fainzilber
Journal:  Mol Biol Evol       Date:  2001-02       Impact factor: 16.240

2.  Stability and structure-forming properties of the two disulfide bonds of alpha-conotoxin GI.

Authors:  A Kaerner; D L Rabenstein
Journal:  Biochemistry       Date:  1999-04-27       Impact factor: 3.162

3.  Selenopeptide analogs of EETI-II retain potent trypsin inhibitory activities.

Authors:  Aleksandra Walewska; Anna Jaśkiewicz; Grzegorz Bulaj; Krzysztof Rolka
Journal:  Chem Biol Drug Des       Date:  2010-10-19       Impact factor: 2.817

Review 4.  Ziconotide: neuronal calcium channel blocker for treating severe chronic pain.

Authors:  G P Miljanich
Journal:  Curr Med Chem       Date:  2004-12       Impact factor: 4.530

5.  Peltophorum dubium and soybean Kunitz-type trypsin inhibitors induce human Jurkat cell apoptosis.

Authors:  María F Troncoso; Verónica A Biron; Silvia A Longhi; Lilia A Retegui; Carlota Wolfenstein-Todel
Journal:  Int Immunopharmacol       Date:  2007-02-02       Impact factor: 4.932

6.  kappa-Conotoxin PVIIA is a peptide inhibiting the shaker K+ channel.

Authors:  K J Shon; M Stocker; H Terlau; W Stühmer; R Jacobsen; C Walker; M Grilley; M Watkins; D R Hillyard; W R Gray; B M Olivera
Journal:  J Biol Chem       Date:  1998-01-02       Impact factor: 5.157

7.  A new family of conotoxins that blocks voltage-gated sodium channels.

Authors:  J M McIntosh; A Hasson; M E Spira; W R Gray; W Li; M Marsh; D R Hillyard; B M Olivera
Journal:  J Biol Chem       Date:  1995-07-14       Impact factor: 5.157

8.  Diversity of Conus neuropeptides.

Authors:  B M Olivera; J Rivier; C Clark; C A Ramilo; G P Corpuz; F C Abogadie; E E Mena; S R Woodward; D R Hillyard; L J Cruz
Journal:  Science       Date:  1990-07-20       Impact factor: 47.728

9.  muO-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits.

Authors:  J Ekberg; A Jayamanne; C W Vaughan; S Aslan; L Thomas; J Mould; R Drinkwater; M D Baker; B Abrahamsen; J N Wood; D J Adams; M J Christie; R J Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-31       Impact factor: 11.205

10.  KNOTTIN: the knottin or inhibitor cystine knot scaffold in 2007.

Authors:  Jérôme Gracy; Dung Le-Nguyen; Jean-Christophe Gelly; Quentin Kaas; Annie Heitz; Laurent Chiche
Journal:  Nucleic Acids Res       Date:  2007-11-19       Impact factor: 16.971

View more
  3 in total

1.  Interactions of disulfide-deficient selenocysteine analogs of μ-conotoxin BuIIIB with the α-subunit of the voltage-gated sodium channel subtype 1.3.

Authors:  Brad R Green; Min-Min Zhang; Sandeep Chhabra; Samuel D Robinson; Michael J Wilson; Addison Redding; Baldomero M Olivera; Doju Yoshikami; Grzegorz Bulaj; Raymond S Norton
Journal:  FEBS J       Date:  2014-06-09       Impact factor: 5.542

2.  Expanding chemical diversity of conotoxins: peptoid-peptide chimeras of the sodium channel blocker μ-KIIIA and its selenopeptide analogues.

Authors:  Aleksandra Walewska; Tiffany S Han; Min-Min Zhang; Doju Yoshikami; Grzegorz Bulaj; Krzysztof Rolka
Journal:  Eur J Med Chem       Date:  2013-05-01       Impact factor: 6.514

3.  On the importance of oxidative folding in the evolution of conotoxins: cysteine codon preservation through gene duplication and adaptation.

Authors:  Andrew M Steiner; Grzegorz Bulaj; Nicolas Puillandre
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.